Lifestyle Delivery Systems Inc. (LDSYF) Has Been Approved by the Bureau of Cannabis Control for a Provisional California State Transportation

Lifestyle Delivery Systems Inc. (LDS.CN), (LDSYF) and ( Frankfurt : LD6, WKN: A14XHT) (“LDS” or the “Company”) announces that on May 7, 2019 , the Bureau of Cannabis Control approved CSPA Group, Inc. for a Provisional Transportation and Distribution License. This provisional license is the last step before a permanent annual license is issued.

Brad Eckenweiler , CEO of LDS, stated, “The issuance of this provisional transportation and distribution license is just one more brick in the vertically-integrated foundation of the LDS family of subsidiaries, licensees and their operations. The provisional license is the precursor to issuance of the permanent annual transportation and distribution license.” The corporate compliance team continues to work on all aspects of SOPs and regulatory compliance, including implementation of operational best practices in all of our licensed activities. The Company will continue to update the market on all relevant events and accomplishments related to the LDS companies.

About Lifestyle Delivery Systems Inc.

The Company’s technology produces infused strips (similar to breath strips) that are not only a safer, healthier option to smoking, but also a new way to accurately meter the dosage and assure the purity of the product. In addition, with the acquisition of Core Isogenics Inc. and CSPA Group, Inc., the Company has begun its direct involvement in the growing of medicinal ingredients for, and the manufacturing of, its products.  From seed to sale, the Company’s products and ingredients will be tested for quality and composition throughout the formulation and production processes, resulting in a delivery system that is safe, consistent and effective.

On behalf of the board of directors of Lifestyle Delivery Systems Inc.
Brad Eckenweiler , CEO & Director

FOR MORE INFORMATION, PLEASE CONTACT:
investor.relations@lifestyledeliverysystems.com
1-866-347-5058

Cautionary Disclaimer Statement:

The Canadian Securities Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of the content of this news release.

Information set forth in this news release contains forward-looking statements that are based on assumptions as of the date of this news release. These statements reflect management’s current estimates, beliefs, intentions and expectations. They are not guarantees of future performance. The Company cautions that all forward looking statements are inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond the Company’s control. Such factors include, among other things: risks and uncertainties relating to the Company’s limited operating history and the need to comply with environmental and governmental regulations. In addition, marijuana remains a Schedule I drug under the United States Controlled Substances Act of 1970.  Although Congress has prohibited the US Justice Department from spending federal funds to interfere with the implementation of state medical marijuana laws, this prohibition must be renewed each year to remain in effect.  Accordingly, actual and future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward looking information. Except as required under applicable securities legislation, The Company undertakes no obligation to publicly update or revise forward-looking information.